PaySign (NASDAQ:PAYS) Price Target Increased to $4.50 by Analysts at DA Davidson

PaySign (NASDAQ:PAYS) had its target price raised by DA Davidson from $4.00 to $4.50 in a research report sent to investors on Monday morning, Benzinga reports. DA Davidson currently has a buy rating on the stock.

Other research analysts have also issued reports about the company. Barrington Research reissued an outperform rating and set a $5.50 target price on shares of PaySign in a report on Wednesday, March 27th. TheStreet raised shares of PaySign from a d+ rating to a c- rating in a research report on Wednesday, January 3rd.

PaySign Price Performance

Shares of PaySign stock opened at $4.11 on Monday. The company has a market capitalization of $216.82 million, a P/E ratio of 34.25 and a beta of 1.06. The business has a 50-day moving average of $3.14 and a two-hundred day moving average of $2.56. PaySign has a 1 year low of $1.67 and a 1 year high of $4.53.

Insiders Place Their Bets

In other news, insider Topline Capital Management, Ll purchased 19,098 shares of the company’s stock in a transaction dated Tuesday, January 23rd. The stock was bought at an average cost of $2.74 per share, for a total transaction of $52,328.52. Following the purchase, the insider now owns 5,375,970 shares of the company’s stock, valued at $14,730,157.80. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, major shareholder Topline Capital Partners, Lp bought 73,000 shares of the firm’s stock in a transaction on Wednesday, January 24th. The stock was acquired at an average price of $2.80 per share, with a total value of $204,400.00. Following the transaction, the insider now owns 5,448,970 shares of the company’s stock, valued at approximately $15,257,116. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, insider Topline Capital Management, Ll acquired 19,098 shares of PaySign stock in a transaction dated Tuesday, January 23rd. The stock was purchased at an average cost of $2.74 per share, for a total transaction of $52,328.52. Following the completion of the purchase, the insider now owns 5,375,970 shares in the company, valued at approximately $14,730,157.80. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 691,570 shares of company stock valued at $2,046,811. 23.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of PAYS. BlackRock Inc. raised its holdings in PaySign by 264.6% during the second quarter. BlackRock Inc. now owns 1,790,007 shares of the company’s stock worth $4,386,000 after buying an additional 1,299,026 shares during the last quarter. State Street Corp raised its holdings in shares of PaySign by 288.2% in the 2nd quarter. State Street Corp now owns 457,834 shares of the company’s stock worth $1,122,000 after acquiring an additional 339,891 shares during the last quarter. Geode Capital Management LLC lifted its position in PaySign by 108.6% in the 2nd quarter. Geode Capital Management LLC now owns 594,005 shares of the company’s stock valued at $1,455,000 after acquiring an additional 309,184 shares in the last quarter. Northern Trust Corp boosted its stake in PaySign by 399.5% during the 2nd quarter. Northern Trust Corp now owns 275,830 shares of the company’s stock valued at $676,000 after purchasing an additional 220,610 shares during the last quarter. Finally, Jane Street Group LLC bought a new stake in PaySign during the 1st quarter worth approximately $601,000. Institutional investors and hedge funds own 25.89% of the company’s stock.

About PaySign

PaySign, Inc provides prepaid card products and processing services under the PaySign brand for corporate, consumer, and government applications. It offers various services, such as transaction processing, cardholder enrollment, value loading, data and analytics, and customer services. The company also offers corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts.